Common TitleStudy 105
Official Title A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of Cobicistat (GS-9350)-boosted Atazanavir (ATV/Cobicistat [GS-9350]) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Phase Phase II
ClinicalTrials.gov NCT00892437
Treatments
Atazanavir-Cobicistat
, Atazanavir-Cobicistat
Tradename:EvotazOther Names:ATV-COBIClass:Protease Inhibitors (PI)Cobicistat
Cobicistat
Tradename:TybostOther Names:COBIClass:Pharmacokinetic EnhancersCategories Treatment-Naive
Funding
IndustryGilead Sciences
References
- Elion R, Cohen C, Gathe J, et al. Phase 2 study of cobicistat versus ritonavir each with once-daily atazanavir and fixed-dose emtricitabine/tenofovir df in the initial treatment of HIV infection. AIDS. 2011;25:1881-6.